Home > Publications database > Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein > print

001     613886
005     20250929153700.0
024 7 _ |a 10.1016/j.celrep.2023.112142
|2 doi
024 7 _ |a 2211-1247
|2 ISSN
024 7 _ |a 2639-1856
|2 ISSN
024 7 _ |a 10.3204/PUBDB-2024-05665
|2 datacite_doi
024 7 _ |a altmetric:142878259
|2 altmetric
024 7 _ |a pmid:36827185
|2 pmid
024 7 _ |a WOS:000944867800001
|2 WOS
024 7 _ |a openalex:W4321485410
|2 openalex
037 _ _ |a PUBDB-2024-05665
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hellert, Jan
|0 P:(DE-H253)PIP1021264
|b 0
245 _ _ |a Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein
260 _ _ |a [New York, NY]
|c 2023
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1729067201_2596425
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a La Crosse virus, responsible for pediatric encephalitis in the United States, and Schmallenberg virus, a highly teratogenic veterinary virus in Europe, belong to the large Orthobunyavirus genus of zoonotic arthropod-borne pathogens distributed worldwide. Viruses in this under-studied genus cause CNS infections or fever with debilitating arthralgia/myalgia syndromes, with no effective treatment. The main surface antigen, glycoprotein Gc (∼1,000 residues), has a variable N-terminal half (GcS) targeted by the patients’ antibody response and a conserved C-terminal moiety (GcF) responsible for membrane fusion during cell entry. Here, we report the X-ray structure of post-fusion La Crosse and Schmallenberg virus GcF, revealing the molecular determinants for hairpin formation and trimerization required to drive membrane fusion. We further experimentally confirm the role of residues in the fusion loops and in a vestigial endoplasmic reticulum (ER) translocation sequence at the GcS-GcF junction. The resulting knowledge provides essential molecular underpinnings for future development of potential therapeutic treatments and vaccines.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
536 _ _ |a ZAPI - Zoonotic Anticipation and Preparedness Initiative (115760)
|0 G:(EU-Grant)115760
|c 115760
|f IMI-JU-11-2013
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |0 EXP:(DE-MLZ)NOSPEC-20140101
|5 EXP:(DE-MLZ)NOSPEC-20140101
|e No specific instrument
|x 0
700 1 _ |a Aebischer, Andrea
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Haouz, Ahmed
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Guardado-Calvo, Pablo
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Reiche, Sven
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Beer, Martin
|0 P:(DE-HGF)0
|b 5
|e Corresponding author
700 1 _ |a Rey, Félix A.
|0 0000-0002-9953-7988
|b 6
|e Corresponding author
773 _ _ |a 10.1016/j.celrep.2023.112142
|g Vol. 42, no. 3, p. 112142 -
|0 PERI:(DE-600)2649101-1
|n 3
|p 112142
|t Cell reports
|v 42
|y 2023
|x 2211-1247
856 4 _ |y OpenAccess
|u https://bib-pubdb1.desy.de/record/613886/files/1-s2.0-S2211124723001535-main.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://bib-pubdb1.desy.de/record/613886/files/1-s2.0-S2211124723001535-main.pdf?subformat=pdfa
909 C O |o oai:bib-pubdb1.desy.de:613886
|p openaire
|p open_access
|p driver
|p VDB
|p ec_fundedresources
|p dnbdelivery
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 0
|6 P:(DE-H253)PIP1021264
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-26
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2022
|d 2023-10-26
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:49:39Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:49:39Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-26
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
920 1 _ |0 I:(DE-H253)CSSB-LIV-KG-20220525
|k CSSB-LIV-KG
|l CSSB - Leibniz-Institut für Experimentelle Virologie (LIV) - Kay Grünewald
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)CSSB-LIV-KG-20220525
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21